In re Remicade Antitrust Litig.
District Court, E.D. Pennsylvania
1Opinion of the CourtJoyner, District Judge
Before the Court are Defendants' Johnson & Johnson and Janssen Biotech, Inc. (collectively "Janssen") ("J & J") Motion to Dismiss for failure to state a claim under Fed. R. Civ. P. 12(b)(6) (Doc. No. 67-1), Indirect and Direct Purchaser Plaintiffs' Joint Opposition thereto (Doc. No. 73), and Defendants' Reply in Support thereof (Doc. No. 75).
I. Background
This case arises from an antitrust action brought by Direct and Indirect Purchasers of Defendants' drug Remicade, against Johnson & Johnson, along with its wholly owned subsidiary, Janssen Biotech, Inc. (collectively, "J & J"), alleging…
2Cases cited73 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Lewis v. CaseySupreme Court of the United States · 1996
68 more not listed; retrieve them via the Exa API.
3Cited by13 opinions
- In re Generic Pharm. Pricing Antitrust Litig.District Court, E.D. Pennsylvania · 2019
- Presque IsleColon & Rectal Surgery v. Highmark HealthDistrict Court, W.D. Pennsylvania · 2019
- A & B Campbell Family v. Chesakpeake Energy CorporationDistrict Court, M.D. Pennsylvania · 2024
- A&B Campbell Family LLC, et al. v. Williams Partners, L.P., et al.District Court, M.D. Pennsylvania · 2025
- LIBERTY TOWERS PHILLY LP v. AMERICAN TOWER CORPORATIONDistrict Court, E.D. Pennsylvania · 2020
8 more not listed; retrieve them via the Exa API.